SEARCH

SEARCH BY CITATION

References

  • Alexander SP, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2): S1S209.
  • Asada M, Yasuda H, Ebihara S, Tomita N, Suzuki S, Sato M et al. (2006). IL-1β gene polymorphisms associated with risk of lung cancer in Japanese. Lung Cancer 54: 261263.
  • Balkwill F, Mantovani A (2001). Inflammation and cancer: back to Virchow? Lancet 357: 539545.
  • Bauman JE, Eaton KD, Martins RG (2007). Antagonism of platelet-derived growth factor receptor in non small cell lung cancer: rationale and investigations. Clin Cancer Res 13: s4632s4636.
  • Berasain C, Perugorria MJ, Latasa MU, Castillo J, Goni S, Santamaria M et al. (2009). The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med (Maywood) 234: 713725.
  • Bieniasz M, Bartkowiak J, Szemraj J (2008). Expression of bone morphogenetic proteins, matrix metalloproteinases and inhibitors of matrix metalloproteinases in lung cancers and their prognostic significance. Postepy Biochem 54: 8290.
  • Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH, Parsons SJ (1999). c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem 274: 83358343.
  • Chen CJ, Wu HY, Chuang YC, Chang AS, Luh KT, Chao HH et al. (1990). Epidemiologic characteristics and multiple risk factors of lung cancer in Taiwan. Anticancer Res 10: 971976.
  • Cheng CY, Hsieh HL, Sun CC, Lin CC, Luo SF, Yang CM (2009). IL-1β induces urokinase-plasminogen activator expression and cell migration through PKCα, JNK1/2, and NF-κB in A549 cells. J Cell Physiol 219: 183193.
  • Cooper KL, Myers TA, Rosenberg M, Chavez M, Hudson LG (2004). Roles of mitogen activated protein kinases and EGF receptor in arsenite-stimulated matrix metalloproteinase-9 production. Toxicol Appl Pharmacol 200: 177185.
  • Darieva Z, Lasunskaia EB, Campos MN, Kipnis TL, Da Silva WD (2004). Activation of phosphatidylinositol 3-kinase and c-Jun – N-terminal kinase cascades enhances NF-κB-dependent gene transcription in BCG-stimulated macrophages through promotion of p65/p300 binding. J Leukoc Biol 75: 689697.
  • Datta SR, Brunet A, Greenberg ME (1999). Cellular survival: a play in three Akts. Genes Dev 13: 29052927.
  • De VF, Orditura M, Auriemma A, Infusino S, Catalano G (1998). Serum concentrations of proinflammatory cytokines in advanced non small cell lung cancer patients. J Exp Clin Cancer Res 17: 413417.
  • Egeblad M, Werb Z (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161174.
  • Elshaw SR, Henderson N, Knox AJ, Watson SA, Buttle DJ, Johnson SR (2004). Matrix metalloproteinase expression and activity in human airway smooth muscle cells. Br J Pharmacol 142: 13181324.
  • Furuyama A, Hosokawa T, Mochitate K (2008). IL-1β and TNF-α have opposite effects on fibroblasts and epithelial cells during basement membrane formation. Matrix Biol 27: 429440.
  • Graves LM, Han J, Earp HS (2002). Transactivation of the EGF Receptor: is the PDGF receptor an unexpected accomplice? Mol Interv 2: 208212.
  • Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001). Cancer statistics, 2001. CA Cancer J Clin 51: 1536.
  • Gschwind A, Zwick E, Prenzel N, Leserer M, Ullrich A (2001). Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 20: 15941600.
  • Gueders MM, Foidart JM, Noel A, Cataldo DD (2006). Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 533: 133144.
  • Hatamochi A, Kuroda K, Shinkai H, Kohma H, Oishi Y, Inoue S (1998). Regulation of matrix metalloproteinase (MMP) expression in cutis laxa fibroblasts: upregulation of MMP-1, MMP-3 and MMP-9 genes but not of the MMP-2 gene. Br J Dermatol 138: 757762.
  • Hurtado M, Lozano JJ, Castellanos E, Lopez-Fernandez LA, Harshman K, Martinez A et al. (2007). Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells. Gut 56: 12661274.
  • Iniesta P, Moran A, De JC, Gomez A, Hernando F, Garcia-Aranda C et al. (2007). Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer. Oncol Rep 17: 217223.
  • Jumper C, Cobos E, Lox C (2004). Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment. Respir Med 98: 173177.
  • Kelly EA, Busse WW, Jarjour NN (2000). Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med 162: 11571161.
  • Kopczynska E, Dancewicz M, Kowalewski J, Kardymowicz H, Tyrakowski T (2007). The serum concentration of metalloproteinase 9 and 2 in non-small cell lung cancer patients. Pol Merkur Lekarski 22: 539541.
  • Lee CW, Lin CC, Lin WN, Liang KC, Luo SF, Wu CB et al. (2007). TNF-α induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-κB/p300 binding in human tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 292: L799L812.
  • Lee YC, Wu CT, Shih JY, Jou YS, Chang YL (2004). Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers. Br J Cancer 90: 23782383.
  • Lin CC, Lee CW, Chu TH, Cheng CY, Luo SF, Hsiao LD et al. (2007). Transactivation of Src, PDGF receptor, and Akt is involved in IL-1β-induced ICAM-1 expression in A549 cells. J Cell Physiol 211: 771780.
  • Lin CC, Tseng HW, Hsieh HL, Lee CW, Wu CY, Cheng CY et al. (2008). TNF-α induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-κB in A549 cells. Toxicol Appl Pharmacol 229: 386398.
  • Lin CC, Kuo CT, Cheng CY, Wu CY, Lee CW, Hsieh HL et al. (2009). IL-1β promotes A549 cell migration via MAPKs/AP-1- and NF-κB-dependent matrix metalloproteinase-9 expression. Cell Signal 21: 16521662.
  • Metro G, Finocchiaro G, Toschi L, Bartolini S, Magrini E, Cancellieri A et al. (2006). Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC). Rev Recent Clin Trials 1: 113.
  • Mook OR, Frederiks WM, Van Noorden CJ (2004). The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705: 6989.
  • Nee L, Tuite N, Ryan MP, McMorrow T (2007). TNF-α and IL-1β-mediated regulation of MMP-9 and TIMP-1 in human glomerular mesangial cells. Nephron Exp Nephrol 107: e73e86.
  • Offersen BV, Pfeiffer P, Andreasen P, Overgaard J (2007). Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis. Lung Cancer 56: 4350.
  • Ongusaha PP, Kwak JC, Zwible AJ, Macip S, Higashiyama S, Taniguchi N et al. (2004). HB-EGF is a potent inducer of tumor growth and angiogenesis. Cancer Res 64: 52835290.
  • Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB (1999). NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 8285.
  • Pepper MS (2001). Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21: 11041117.
  • Rao JS, Gondi C, Chetty C, Chittivelu S, Joseph PA, Lakka SS (2005). Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. Mol Cancer Ther 4: 13991408.
  • Reddy SA, Huang JH, Liao WS (2000). Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-κB activation. J Immunol 164: 13551363.
  • Reichenberger F, Eickelberg O, Wyser C, Perruchoud AP, Roth M, Tamm M (2001). Distinct endobronchial expression of matrix-metalloproteinases (MMP) and their endogenous inhibitors in lung cancer. Swiss Med Wkly 131: 273279.
  • Saito Y, Haendeler J, Hojo Y, Yamamoto K, Berk BC (2001). Receptor heterodimerization: essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation. Mol Cell Biol 21: 63876394.
  • Sasaki M, Kashima M, Ito T, Watanabe A, Izumiyama N, Sano M et al. (2000). Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, IL-1β and TNF-α. Mediators Inflamm 9: 155160.
  • Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG (1991). Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem 266: 78707875.
  • Sounni NE, Noel A (2005). Membrane type-matrix metalloproteinases and tumor progression. Biochimie 87: 329342.
  • Visse R, Nagase H (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827839.
  • Wu CY, Hsieh HL, Sun CC, Tseng CP, Yang CM (2008). IL-1β induces proMMP-9 expression via c-Src-dependent PDGFR/PI3K/Akt/p300 cascade in rat brain astrocytes. J Neurochem 105: 14991512.